Shows
Driving the Business of ScienceUnlocking Value: Why Latin America is the Strategic Choice for Phase 1 TrialsIn this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, interviews Sara Tylosky, CEO of Farmacon Global, about the Latin American market for clinical trials. Farmacon Global, a strategic partner with a network of physicians, focuses on rare diseases, oncology, and immunology in Latin America. Sara highlights the region's diversity, cost savings, and fast recruitment, noting that Latin America represents 0.7% of global phase 1 studies but has a population of more than 660 million and 30+ qualified sites. She addresses misconceptions about slow recruitment and regulatory issues, emphasizing the region's alignment with...
2025-07-1823 min
Molecule to Market: Inside the outsourcing spaceThe LATAM CRO QueenIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sara Tylosky, CEO at Farmacon Global.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sara, covering:
The gift and curse of being known for rescuing complex clinical trials
The data challenge of rare diseases and how that impacts patient access
Navigating the complexity of rare diseases in Latin America and why it all starts with education
How her father's role in building space stations globally inspired her own international business journey
Th...
2025-03-0747 min